Phone Outreach Nudges Among Individuals Losing Medicaid Coverage

June 10, 2024 updated by: Marina Lovchikova, Covered California

Evaluating Impact of Outreach Nudges Among Individuals Losing Medicaid Coverage in California

In May 2023, Covered California, California's ACA marketplace, implemented its automatic enrollment program for individuals losing Medicaid coverage, as defined by Senate Bill 260. If individuals are found eligible for subsidized marketplace coverage, individuals will be automatically enrolled in the lowest cost silver plan available to them, but individuals must still take action to confirm their plan or pay their first month's premium. To identify whether the phone outreach is the effective outreach strategy to increase take-up in this population, Covered California implemented this intervention. The results of this evaluation will inform operational and budgeting decisions.

Study Overview

Status

Enrolling by invitation

Study Type

Interventional

Enrollment (Estimated)

60045

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95835
        • Covered California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Lost Medi-Cal (California's Medicaid coverage) in July 2023-June 2024
  • Auto-enrolled into lowest cost silver plan with Covered California as per Senate Bill 260 and have not opted-in (effectuated) into the coverage
  • Have a valid phone number on the health insurance application
  • Do not have a delegated agent to their case
  • Still have Covered California Program eligibility, not reverted back to Medi-Cal coverage
  • Have English or Spanish as preferred speaking language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Group without a phone call
Control Group was assigned to receive no phone outreach
Standard notification letter without phone outreach to individuals losing Medicaid and auto-enrolled into Covered California plan to nudge them to act
Experimental: Treatment Group with a phone call
Treatment group was assigned to receive a phone call from Covered California call center
Phone outreach to individuals losing Medicaid and auto-enrolled into Covered California plan to nudge them to act

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Plan Effectuation
Time Frame: within 30 days from the start date of plan they are auto-enrolled into
A binary indicator for whether a consumer is effectuated into (paid for, opt-in into) Covered California plan, either the plan assigned through the auto-enrollment process, or into another plan chosen by the consumer by the end of the month at which outreach was conducted
within 30 days from the start date of plan they are auto-enrolled into

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tenure with Covered California (measured in months)
Time Frame: measured 1-2 years after the intervention
A length of tenure with Covered California plan within calendar year and/or beyond
measured 1-2 years after the intervention
Office visit
Time Frame: measured 1-2 years after the intervention
A binary indicator for whether someone had an office visit during 1-2 years since the intervention
measured 1-2 years after the intervention
Prescriptions filled
Time Frame: measured 1-2 years after the intervention
A binary indicator for whether someone had a prescription drug fill during 1-2 years since the intervention
measured 1-2 years after the intervention
Emergency Room Visit
Time Frame: measured 1-2 years after the intervention
A binary indicator for whether someone had an emergency room visit during 1-2 years since the intervention
measured 1-2 years after the intervention
Hospital admission
Time Frame: 1-2 years before and after the intervention
A binary indicator for whether someone had a hospital admission 1-2 years before and 1-2 years after the intervention
1-2 years before and after the intervention
Out-of-pocket spending on healthcare services
Time Frame: measured 1-2 years after the intervention
Total out-of-pocket spending for the 1-2 years since the intervention
measured 1-2 years after the intervention
Uninsured
Time Frame: measured 1-2 years after the intervention
A binary indicator for whether someone self-reported being uninsured while filing their taxes
measured 1-2 years after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emory Wolf, MPP, Covered California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

November 1, 2024

Study Registration Dates

First Submitted

June 5, 2024

First Submitted That Met QC Criteria

June 10, 2024

First Posted (Actual)

June 12, 2024

Study Record Updates

Last Update Posted (Actual)

June 12, 2024

Last Update Submitted That Met QC Criteria

June 10, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SB260-OCC-2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The researchers are committed to sharing as much data as possible for replication, consistent with the privacy and security requirements of the state agency that govern the re-disclosure of the data.

IPD Sharing Time Frame

Data will be available with investigator support upon publication

IPD Sharing Access Criteria

Replication data can be accessed via request to the primary investigator upon publication.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavioral Economics

Clinical Trials on Standard Notice

Subscribe